February is set to be a pivotal month for drug approvals, with the FDA poised to deliver three critical decisions. One of these could be … Read more
Fulcrum Therapeutics’ hopes for its potential sickle cell disease (SCD) treatment, FTX-6058, have been put on hold after the US Food and Drug Administration (FDA) … Read more
In an unprecedented year for uniQure, the Massachusetts and Amsterdam-based biotechnology company made history with the U.S. and European approval of the world’s first gene … Read more
Be a part of the puzzle in the ever-evolving therapeutic world with GALLS – a 5,000-piece jigsaw that’s connecting the regulatory edges. As you put … Read more
Reata Pharmaceuticals’ dream of becoming the first to secure FDA approval for an effective treatment of Friedreich’s ataxia (FA) has been put on hold after … Read more
Seagen, the Seattle-based biotech firm, is back in the spotlight after reportedly entering into discussions with pharmaceutical giant Pfizer for a possible acquisition. According to … Read more
After a tumultuous tenure, FDA neuroscience head Dr. Billy Dunn is leaving his post to pursue other opportunities. An internal FDA e-mail revealed the news, … Read more
Alvotech, a global biotech leader in the development and manufacture of life-saving biosimilar medicines, will release its financial results for full year 2022 on Wednesday, … Read more
As the world celebrates Rare Disease Day 2023, RemeGen Co., Ltd. (“RemeGen” or “the Company”) (9995.HK, SHA: 688331) stands in solidarity with the millions of … Read more
Thrive Bioscience Inc. is revolutionizing the field of live cell imaging with their newest Release 4.0 of their CellAssist software. This integrated suite of groundbreaking … Read more
Junshi Biosciences is celebrating a major milestone, having successfully completed two randomized, double-blind, placebo-controlled, multi-center phase III clinical studies (Study nos.: JS002-003 and JS002-006) of … Read more
PharmAla Biotech (CSE:MDMA) is thrilled to announce the unveiling of a revolutionary Patent Cooperation Treaty (PCT) application containing 6 Novel Chemical Entities (NCEs). This application, … Read more
In a move to further streamline its business, Jounce Therapeutics has unveiled an all-stock merger with the clinical-stage biotech Redx Pharma. This restructuring initiative marks … Read more
AbbVie, a global biopharmaceutical company, and Capsida Biotherapeutics have just announced a major collaboration that could potentially change the treatment of eye diseases. With a … Read more
Moderna ended 2022 with a bang, thanks to the success of their Spikevax sales. As they look forward to 2023, the company is investing heavily … Read more
Novartis has decided to discontinue its ex vivo sickle cell disease (SCD) program, which was developed using Intellia Therapeutics’ CRISPR gene editing technology. This news … Read more
Graphite Bio has pulled the plug on its much-anticipated gene therapy for sickle cell disease (SCD), nulabeglogene autogedtemcel (nula-cel). The end of the development of … Read more
Today is World Cochlear Implant Day and MED-EL, a leader in implantable hearing solutions, is celebrating with the millions of people whose lives have been … Read more
Praxis Spinal Cord Institute is thrilled to welcome three cutting-edge technologies to their SCI Incubate program for 2023 — Battelle, inContAlert, and Focal Lines Technologies … Read more
InnoCare Pharma (HKEX: 09969; SSE: 688428) and Keymed Biosciences (HKEX: 02162) made a joint announcement today: the first patient has been dosed with ICP-B05 (CM369), … Read more
Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078) is thrilled to invite you to join its conference call on March 2, 2023 at 2:00 pm CET … Read more
PharmaEssentia USA Corporation, a subsidiary of global biopharmaceutical innovator PharmaEssentia Corporation (TPEx:6446), has recently initiated a Phase 2b clinical trial to assess the efficacy of … Read more
AceLink Therapeutics, Inc. has unveiled promising results from their Phase 1 trial of AL01211, a novel therapeutic for genetic diseases. The study demonstrated the medication’s … Read more
AceLink Therapeutics, Inc., a pioneering biopharmaceutical company dedicated to creating life-changing treatments for genetic diseases, has unveiled the promising early results of AL00804, an oral … Read more
Covalon Technologies Ltd. (the “Company” or “Covalon”), an advanced medical technologies company, is pleased to announce its first quarter fiscal 2023 results, ending December 31, … Read more
Glooko Inc. is thrilled to announce a partnering agreement with Sanofi US to better support people living with diabetes and healthcare professionals. The integration of … Read more
Omega Therapeutics, Inc. (Nasdaq: OMGA) has secured an impressive $40 million in a registered direct offering of 6,920,415 Shares of common stock, with a purchase … Read more
Aprea Therapeutics, Inc. (Nasdaq: APRE) is excited to announce the pricing of its public offering of 1,050,000 shares of common stock at a public offering … Read more
At the 19th Annual WORLDSymposium 2023, Astellas presented promising preliminary safety and efficacy data from their Phase I/II FORTIS trial of AT845 in late-onset Pompe … Read more
Apellis Pharmaceuticals, Inc. (Nasdaq:APLS) is excited to announce the pricing of its public offering of 3,174,603 shares of common stock and pre-funded warrants to purchase … Read more
Keymed Biosciences Inc. and Lepu Biopharma Co., Ltd. have today made a landmark agreement with AstraZeneca, granting them exclusive global rights to develop, manufacture and … Read more
On Monday, March 6, 2023, Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, will be releasing their fourth quarter 2022 financial results … Read more
Processa Pharmaceuticals (Heatwurx Acquired Promet), Inc. (Nasdaq: PCSA) (“Processa” or the “Company”) is focused on developing its Next Generation Chemotherapies (NGCs) to improve the safety-efficacy … Read more
Myeloid Therapeutics Inc., a clinical-stage mRNA-immunotherapy company, is taking a major step towards the commercialization of its RNA therapeutics with the announcement of a collaboration … Read more
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) is pleased to announce that management will be participating in Cowen’s 43rd Annual Health Care Conference on Tuesday, March 7, … Read more
Today, IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) announced that An van Es-Johansson has chosen to step down from her role as a member of … Read more
CareDx, Inc. (Nasdaq: CDNA), The Transplant Company™, is set to report its financial results for the fourth quarter and full year 2022 on Monday, February … Read more
CSL, a global leader in biotechnology, has once again been recognized as one of America’s Best Employers by Forbes and Statista. This is a testament … Read more
Making the transition from academia to industry can be a daunting prospect, but it is often necessary for researchers to bring their therapeutic visions to … Read more
The targeted radiotherapy candidate proved a resounding success, with an impressive 75% of patients achieving initial remission after bone marrow transplant (BMT), compared to a … Read more
Akebia Therapeutics has suffered yet another major setback in the development of vadadustat, a drug designed to treat anemia caused by chronic kidney disease. This … Read more
Pfizer made a major stride forward in the race for an RSV vaccine on Tuesday, as the US Food and Drug Administration (FDA) accepted its … Read more
Hemab Therapeutics has secured a whopping $135 million in its Series B funding round, significantly surpassing its target and paving the way for new treatments … Read more
Ipsen S.A.’s Anemone Acquisition Corp. has extended their tender offer to purchase all of Albireo Pharma, Inc.’s outstanding shares of common stock, at a price … Read more
Relation Therapeutics has taken a major step forward in realising their ambition to establish a revolutionary approach to drug discovery with the opening of their … Read more
C4X Discovery Holdings plc (AIM: C4XD), a pioneering Drug Discovery company, is thrilled to announce the launch of PatientSeek, a groundbreaking precision medicine platform. This … Read more
LinKinVax, a clinical-stage biotechnology company, is thrilled to announce the promising interim results of the ANRS VRI06 Phase I trial evaluating a preventive HIV vaccine. … Read more
NRG Therapeutics, Ltd., a pioneering neuroscience company taking on mitochondrial dysfunction, is delighted to announce that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) … Read more
Vivek Ramaswamy, the founder of Roivant Sciences (Nasdaq: ROIV), has taken a bold step and resigned from his board position to focus on his ambitious … Read more
Avidity Biosciences, Inc. (Nasdaq: RNA) recently granted 27,400 stock options and 13,700 restricted stock units (RSUs) to three new non-executive employees as part of the … Read more
The FDA has just approved Syfovre (pegcetacoplan), developed by Apellis Pharmaceuticals, as the first ever treatment for geographic atrophy (GA). This rare form of blindness … Read more
Eisai is on the brink of a major breakthrough this summer, with the potential full FDA approval of Leqembi (lecanemab), a new drug for Alzheimer’s, … Read more
Thursday brought a flurry of news from Moderna as the company announced the interim results from its Phase III trial of mRNA-1010, a seasonal flu … Read more
Pfizer and Valneva have dealt a major blow to the development of their Lyme disease vaccine candidate, VLA15, after they uncovered potential violations of good … Read more
Clover Biopharmaceuticals, Ltd. is proud to announce an exclusive agreement with Adimmune Corporation that enables Clover to distribute AdimFlu-S (QIS) in mainland China, Bangladesh, Brazil … Read more
Astellas Pharma Inc. has been granted an extended priority review of its investigational agent ‘Fezolinetant’ by the U.S. Food and Drug Administration. Fezolinetant is being … Read more
At the ASCO Genitourinary Cancers Symposium held in San Francisco, Photocure ASA, The Bladder Cancer Company, presented clinical data from the Veterans Affairs (VA) BRAVO … Read more
Medivir AB, a pharmaceutical company dedicated to developing innovative treatments for cancer, has successfully completed the initial dose escalation phase of its 1b/2a study on … Read more
WestVac Biopharma (Guangzhou) Co., Ltd. has made groundbreaking progress on the development of the world’s first trivalent recombinant protein COVID-19 vaccine against the latest prevalent … Read more
Daewoong Pharmaceutical (led by CEO Seng-ho Jeon and Chang-jae Lee) announced an impressive 2022 annual report. On a standalone basis, sales soared by 10.1% to … Read more
GC Biopharma, a South Korean biopharmaceutical leader, is thrilled to announce that its varicella vaccine, BARYCELA, has been prequalified by the World Health Organization (WHO). … Read more
Applied Therapeutics, Inc. (Nasdaq: APLT) is thrilled to announce encouraging sorbitol reduction results from their ongoing global Phase 3 INSPIRE trial. The trial is evaluating … Read more
CareDx, Inc., a pioneering precision medicine company that is transforming the landscape of healthcare solutions for transplant patients and caregivers, is thrilled to showcase its … Read more
Enveda Biosciences has made a major impact on the medical field since its launch in 2019, raising an impressive $124 million to develop small molecules … Read more
Seagen remained silent on the possibility of a buyout from Merck as they reported their fourth-quarter and full-year financial results Wednesday, leaving investors guessing as … Read more
Grifols, a Spanish drugmaker, made waves on Wednesday with the announcement of a sweeping plan to improve its efficiency and cost-effectiveness. Unfortunately, this move will … Read more
Talaris Therapeutics is undergoing a major restructuring, which includes reducing its workforce by one-third and shifting the focus of its pipeline. This move is poised … Read more
Aera Therapeutics has burst onto the scene Thursday, joining forces between an Alynlam vet and a CRISPR big wig to tackle one of the most … Read more
Today, Daiichi Sankyo Co., Ltd. (TSE: 4568) is pleased to announce that it has been granted its request to re-institute post-grant review (PGR) of the … Read more
Abivax SA, a Phase 3 biotechnology company dedicated to developing treatments to modulate the immune system and treat chronic inflammatory diseases, is delighted to welcome … Read more
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) have made the difficult decision to discontinue the participation of a significant portion … Read more
Ascletis Pharma Inc. (HKEX:1672) is proud to announce that their subcutaneous PD-L1 antibody, ASC22 (Envafolimab), has been found to potentially provide a functional cure for … Read more
Tubulis is proud to announce the appointment of Björn Hock, PhD, as its new Chief Development Officer (CDO). With more than two decades of experience … Read more
Enthera Pharmaceuticals, a biotech company pioneering novel biologics for select autoimmune conditions, is pleased to announce the addition of Filippo Canducci MD, PhD to its … Read more
Innovent Biologics, Group (HKEX: 01801), a world-class biopharmaceutical company, has made a major breakthrough in the treatment of plaque psoriasis with the successful dosing of … Read more
Valneva SE, a specialty vaccine company listed on both Nasdaq and Euronext Paris, reported its revenue and cash balance for the full year 2022 and … Read more
Pharming Group N.V. is pleased to announce that the European Medicines Agency’s Committee for Human Medicinal Products has decided to review its Marketing Authorisation Application … Read more
IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a clinical-stage biopharmaceutical company pioneering the development of novel treatments for Parkinson’s disease, will be releasing its year-end … Read more
Eurofins Viracor LLC, a leader in testing for infectious disease, immunology, and allergy, is proud to announce the launch of a revolutionary test that can … Read more
As the Biden-Harris administration’s approved measures move closer to fruition, government agencies are now facing the challenge of putting these policies into action. With 2023 … Read more
Grifols, a Spanish drugmaker, has unveiled a sweeping plan to streamline operations and reduce costs – a decision that will unfortunately result in the loss … Read more
John Reed is making the leap from Sanofi to Johnson & Johnson, where he is set to become the executive vice president of pharmaceuticals, R&D. … Read more
NeoDynamics is delighted to announce that Jie Bao and Xiaojun Xu will be transitioning away from their roles on the Board of Directors to focus … Read more
Cytovation ASA, a clinical stage immune-oncology company, is excited to report that the first patient has been dosed in its Phase 2a study of CyPep-1, … Read more
Formosa Pharmaceuticals (6838.TWO) has entered into an exciting collaboration with Eyenovia, Inc. (NASDAQ: EYEN) to develop innovative ophthalmic products. This groundbreaking agreement brings together Formosa’s … Read more
Gamma Biosciences, a KKR-formed life sciences platform, has taken a major step in the advanced therapy market with its agreement with Swedish life sciences company … Read more
Cutera, Inc. (Nasdaq: CUTR) is set to report its financial results for the fourth quarter and full year of 2022 after the market close on … Read more
Ipsen, Université de Montréal and IRICoR are excited to announce that Ipsen has exercised its option to acquire exclusive rights to a pre-clinical stage program … Read more
Bavarian Nordic A/S (OMX: BAVA) has just announced a major agreement with Emergent BioSolutions Inc. (NYSE: EBS), acquiring two already-marketed travel vaccines, Vivotif® and Vaxchora®, … Read more
Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP) is pleased to announce the successful closing of its Private Placement of 10,344,822 Units at an issue price of US$0.58 per … Read more
Mainz Biomed is thrilled to announce exciting new partnerships with Marylebone Lab LTD and Instituto de Microecologia, two leading independent laboratories covering England and Spain … Read more
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is proud to announce the launch of a new research and development program dedicated to tackling … Read more
Valo Therapeutics Oy (ValoTx), the innovator of adaptive immunotherapies for cancer and infectious diseases, is delighted to announce that it has been awarded a grant … Read more
Encision Inc. (PK:ECIA) is excited to announce that they have signed a Proof of Concept Services Agreement with Vicarious Surgical Inc. The Agreement comes with … Read more
Insulet Corporation (NASDAQ: PODD) – the leader in cutting-edge tubeless insulin pump technology – is pleased to announce that its management team will be presenting … Read more
Lemonex Inc., a biotechnology company at the forefront of mRNA and siRNA therapeutics, recently submitted an Investigational New Drug (IND) application to the Ministry of … Read more
Avanos Medical, Inc. (NYSE: AVNS) is set to release its financial results and business highlights for the fourth quarter and full year of 2022 during … Read more
BioMed X is proud to announce the launch of a revolutionary immunology discovery platform that will revolutionize the way we identify target antigens of human … Read more
Insulet Corporation (NASDAQ: PODD), the global pioneer in tubeless insulin pump technology, has made a major acquisition today with the assets of Automated Glucose Control … Read more
NanoString Technologies, Inc. (NASDAQ:NSTG) is set to report fourth quarter and fiscal year 2022 operating results on Tuesday, February 28, 2023. The leading provider of … Read more
Cullinan Oncology and Harbour BioMed have teamed up to make a revolutionary breakthrough in cancer treatments, introducing CLN-418/HBM7008- a B7H4 x 4-1BB bispecific immune activator … Read more
Frequency Therapeutics Inc. (Nasdaq: FREQ), a regenerative medicine company pioneering treatments to restore function, unveiled promising clinical results from its Phase 2b study of FX-322, … Read more
MAIA Biotechnology, Inc. (NYSE American: MAIA) is launching its second Phase 2 go-to-market trial to evaluate THIO, the world’s first telomere-targeting agent, as a potential … Read more
Jubilant Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to providing small molecule precision therapeutics to address unmet medical needs in oncology and autoimmune diseases, … Read more
Alligator Bioscience AB and Aptevo Therapeutics are delighted to announce that the first patient has been dosed in the companies’ Phase 1 trial of ALG.APV-527, … Read more
BioNxt Solutions Inc. is thrilled to share an update on its commercialization plan for the transdermal Rotigotine patch, a revolutionary treatment for those living with … Read more
IRRAS, a commercial-stage medical technology company, recently announced the publication of the first comparative study detailing the use of their novel IRRAflow system. This study, … Read more
Astex Pharmaceuticals (UK) and The Medicines Discovery Institute, Cardiff University have joined forces in a multi-million pound, multi-year collaboration to discover novel small molecule therapeutics … Read more
Aristea Therapeutics has made the difficult decision to terminate its Phase II lead program RIST4721 due to safety concerns, resulting in the dissolution of its … Read more
LegoChem Biosciences Inc. (KOSDAQ:141080) has just announced an exciting new license agreement with Elthera AG, a Swiss biotechnology company. This agreement will enable LegoChemBio to … Read more
IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company dedicated to discovering, developing, and manufacturing innovative cell therapies and antibody products, is delighted to announce that … Read more
AstraZeneca made a major shift in priorities Thursday, announcing a sweeping cut to its pipeline of drugs in an effort to counterbalance its declining COVID-19 … Read more
Bayer’s supervisory board has responded to investor and shareholder demands by unanimously appointing Bill Anderson, an outsider, as their new CEO. Anderson will step into … Read more
Magenta Therapeutics has announced a dramatic restructuring that will drastically reduce its workforce, with up to 56 positions being eliminated – a massive 84 percent … Read more
AbbVie’s much-anticipated Humira cliff has arrived, and the biopharma giant is feeling the impact on its 2023 projections. After releasing Q4 and annual 2022 results … Read more
Nykode Therapeutics ASA, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, is teaming up with the GOG Foundation, Inc. to … Read more
Today, Evotec SE – a Frankfurt Stock Exchange-listed MDAX/TecDAX and NASDAQ-traded company – and the European Investment Bank (EIB) are pleased to announce a € … Read more
ALK has announced that Claus Steensen Sølje will join their ranks as Executive Vice President and Chief Financial Officer (CFO) from June 1, 2023. He … Read more
At the BriaCell Therapeutics Corp. Annual General and Special Meeting of Shareholders for the year ended July 31, 2022, a resounding success was seen with … Read more
Nona Biosciences, a cutting-edge technology innovator and wholly-owned subsidiary of HBM Holdings Limited, has entered into an exciting collaboration with Mythic Therapeutics, a biotechnology company … Read more
InMed Pharmaceuticals Inc. has taken the initiative to file a Form 12b-25 with the SEC in connection with its Quarterly Report on Form 10-Q for … Read more
Verily, an Alphabet company focused on precision health, is pleased to announce the appointment of Utpal Koppikar as their new Chief Financial Officer. With an … Read more
Vapotherm Inc. (NYSE: VAPO), a global medical technology company committed to the development and commercialization of its proprietary Vapotherm high velocity therapy® products, has recently … Read more
John Quisel, J.D., Ph.D., Chief Executive Officer and President of Disc Medicine, Inc. (NASDAQ:IRON), will take part in a virtual fireside chat at the SVB … Read more
Halberd Corporation (OTC PINK:HALB) has achieved remarkable success with its patent-pending extracorporeal laser eradication process. Through an experimental process conducted by Dr. Chester Cooper and … Read more
Abbott Laboratories (NYSE: ABT) and Cardiovascular Systems, Inc. (CSI) have reached a deal that will see Abbott acquire CSI, a medical device company with a … Read more
Sterling Medical Devices, a leader in the medical device industry, is proud to announce their merger with RBC Medical Innovations. This strategic move brings additional … Read more
Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) has released its financial and operational results for the third quarter of its fiscal year 2023, ending December 31, … Read more
23andMe, the leading human genetics and biopharmaceutical company, announced its financial results for the third quarter of its fiscal year 2023, ending December 31, 2022. … Read more
ADMA Biologics, Inc. (NASDAQ: ADMA) is excited to announce that the company has received U.S. Food and Drug Administration (“FDA”) approval for its eighth ADMA … Read more
Samsung’s United States headquarters of digital radiography and ultrasound, Boston Imaging, introduces the HERA W10 Elite1; the most advanced model of the HERA platform for … Read more
CHOP has been awarded an incredible $2.3 million from the Bill & Melinda Gates Foundation to power crucial mitochondria medicine research and unlock the mystery … Read more
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI system™, is proud to announce the appointment … Read more
Visage Imaging, Inc., a subsidiary of Pro Medicus Ltd., is thrilled to be the proud recipient of the #1 Universal Viewer (Imaging) ranking in the … Read more
After nearly six years of successful service at Align Technology, Inc., Yuval Shaked, executive vice president and managing director of iTero scanner and services, is … Read more
Jaguar Health Inc. (NASDAQ:JAGX) had good news to share on February 7, 2023, as the Company was notified by The Nasdaq Stock Market LLC (“Nasdaq”) … Read more
Lazurite has announced its schedule of upcoming events, where it will be exhibiting, presenting, or attending in support of its revolutionary ArthroFree® wireless camera system … Read more
Heska Corporation (NASDAQ: HSKA), a leading global provider of advanced veterinary diagnostic and specialty solutions, will reveal its fourth quarter and full year 2022 financial … Read more
Curio Bioscience has just taken a giant leap forward in the world of gene expression mapping with the launch of Curio Seeker – the world’s … Read more
West Pharmaceutical Services, Inc. (NYSE: WST) is proud to announce the expansion of its game-changing collaboration with Corning Incorporated (NYSE: GLW), granting exclusive distribution rights … Read more
EnPlusOne Biosciences, Inc., a biotechnology company utilizing the power of enzymes to synthesize RNA oligonucleotides, is proud to welcome Jonathan K. Watts, Ph.D., to its … Read more
Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company committed to developing therapies for GI complications, is pleased to announce the promotion of Robert … Read more
PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company, has taken a major step forward in the fight against infectious diseases, including SARS-CoV-2 and multiple … Read more
Synos Health®, the leading biopharmaceutical solutions organization, is proud to announce their strategic partnership with Equicare, leveraging proXimity™, a cloud-based software platform that expedites the … Read more
T-knife Therapeutics, Inc., a clinical-stage biopharmaceutical company, is proud to announce the appointment of Behzad Kharabi Masouleh, M.D. as Chief Medical Officer. Dr. Masouleh will … Read more
Nimbus Therapeutics, a clinical-stage company that designs and develops breakthrough medicines, announced the closing of Takeda’s (TSE: 4502/NYSE:TAK) acquisition of its wholly-owned subsidiary, Nimbus Lakshmi, … Read more
Summit Healthcare Acquisition Corp. (Nasdaq: SMIH), and YishengBio Co., Ltd (to be renamed YS Biopharma Co., Ltd.) have received SEC approval for their proposed business … Read more
Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, has released revolutionary proof-of-concept data demonstrating the potential therapeutic cognitive effects of its experimental drug, HT-ALZ, in an … Read more
Ostial Corporation, a revolutionary medical technology company, just announced a major funding milestone: a $7M growth round led by Delos Capital, with AMED Ventures and … Read more
The Mark Foundation for Cancer Research has unveiled the latest round of recipients of its Drug Discovery Award – an ambitious program designed to fast-track … Read more
aTyr Pharma, Inc. (Nasdaq: LIFE) has begun an exciting new public offering of its common stock, giving investors the opportunity to be part of a … Read more
Garuda Therapeutics is revolutionizing the medical field with their groundbreaking cell therapy technology. The company recently secured a $62 million Series B round to further … Read more
Roche and Janssen Biotech Inc. are collaborating to bring the next level of precision medicine to patients. By creating companion diagnostics for targeted therapies, Roche … Read more
Celyad Oncology, a biotechnology company focused on the development of innovative treatments for CAR T-cell therapies, has announced the publication of the data from the … Read more
Lunit and Agfa HealthCare have achieved a major milestone in breast imaging technologies with the successful implementation of the Breast AI Analysis Package at Dubai … Read more
Brendan Swift is joining ATF Medical, a national leader in complex rehab technology and accessibility solutions for workers’ compensation, as Vice President of Payer Partnerships … Read more
Vertex has provided an update on the late-stage clinical development of its next-in-class triple combination treatment for cystic fibrosis, vanzacaftor/tezacaftor/deutivacaftor, amidst increasing demands for generic … Read more
The WHO has bestowed an esteemed honor upon GC Biopharma, the leading biopharmaceutical provider in South Korea. On February 3rd, 2023, the WHO granted prequalification … Read more
The tech industry and the life sciences have been forging an ever-closer alliance in recent years. By 2030, the pharma industry is projected to invest … Read more
In the wake of the opioid crisis, finding long-term, non-addictive solutions to manage chronic pain in the U.S. has become an urgent priority for biopharma, … Read more
On February 9th, the FDA’s Oncologic Drugs Advisory Committee (ODAC) will be discussing GSK’s Jemperli (dostarlimab) and its potential to receive accelerated approval for treatment … Read more
Sensorion, a clinical-stage biotechnology company at the forefront of developing novel therapies for the treatment of hearing loss disorders, is pleased to announce that the … Read more
Pliant Therapeutics launched a public offering of its common stock on Monday, with a total of $175 million up for grabs. The proceeds from the … Read more
Babson Diagnostics is revolutionizing the healthcare industry with its cutting-edge technology, BetterWay™ Blood Testing. This innovative diagnostic blood testing service puts the customer first, ensuring … Read more
CoImmune, Inc., a clinical stage immuno-oncology company working to revolutionize cancer treatment with cutting-edge cellular immunotherapies, has unveiled exciting preclinical results in Blood, the leading … Read more
Cardiff Oncology, Inc. (Nasdaq: CRDF), a forward-thinking biotechnology company developing innovative therapies for a range of cancers, is proud to announce the appointment of Fairooz … Read more
Recent studies have exposed a worrying connection between CRISPR gene editing and ancestry: individuals with greater genomic diversity, such as those of African descent, have … Read more
The US Food and Drug Administration (FDA) has given the green light to GSK’s daprodustat, now branded as Jesduvroq, for treating anemia related to chronic … Read more
Patient Square Capital is rewriting the rules of the game when it comes to investing in bear markets and sky-high inflation. On Thursday, they announced … Read more
Karuna Therapeutics has made an exciting move, acquiring exclusive rights to Goldfinch Bio’s investigational transient receptor potential canonical 4 and 5 (TRPC4/5) channel candidates in … Read more
Roche has decided to discontinue development of its experimental AKT inhibitor ipatasertib, which had been under investigation in a Phase III trial for castration-resistant prostate … Read more
Structure Therapeutics Inc., a clinical-stage global biopharmaceutical company, is pleased to announce the pricing of its upsized initial public offering of 10,740,000 American depositary shares … Read more
Roivant Sciences, Inc. (Nasdaq: ROIV) announced the successful pricing of an upsized public offering of 26,666,666 of its common shares at a price of $7.50 … Read more
Dr. Anton (Tony) Hoos is set to become the new Head of R&D and Medical Affairs, Chief Medical Officer, and member of the Sobi Executive … Read more
Vera Therapeutics, Inc. (NasdaqGM: VERA) is delighted to announce the pricing of its underwritten public offering, offering 14,285,715 shares of its Class A common stock … Read more
TAU Systems, a leading provider of ultrafast, compact plasma accelerators, is proud to announce its recent agreements with The University of Texas at Austin (UT … Read more
BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company dedicated to developing innovative AXL kinase inhibitors to address severe unmet medical needs, is proud to announce … Read more
NeoDynamics AB (Nasdaq First North Growth Market Stockholm: NEOD.ST) is thrilled to announce their new partnership with global distribution and logistics giant Uniphar Group to … Read more
Sequana Medical NV (Euronext Brussels: SEQUA), a leader in the field of fluid overload treatment for liver disease, heart failure and cancer patients, will reveal … Read more
Sensorion, an innovative clinical-stage biotechnology company, is excited to announce their participation in the Association for Research in Otolaryngology (ARO) 46th Annual MidWinter Meeting in … Read more
Fourth quarter Sales of SEK 855 (514) million soared by an impressive 66% in SEK, driven by organic growth of 11%, 37% acquired growth, and … Read more
OCTOBER – DECEMBER IN BRIEF During the quarter, the company achieved net sales of KSEK 142, a significant increase from the KSEK 99 reported in … Read more
Anaveon, a clinical stage immuno-oncology company, is excited to announce the first patient has been dosed in the OMNIA-1 study – a Phase I/II study … Read more
On Tuesday, uniQure announced an exciting collaboration with Apic Bio to develop and commercialize APB-102, a potential therapeutic treatment for a rare, genetic form of … Read more
With a colossal $150 million Series B financing round, Colossal Biosciences has taken a giant leap towards the de-extinction of the beloved Dodo – extinct … Read more
Sirnaomics Ltd., a cutting-edge biopharmaceutical company in the discovery and development of RNAi therapeutics, is thrilled to announce that it is making strides in the … Read more
Occlutech Holding AG, a leader in providing cutting-edge minimally invasive structural heart disease devices, is proud to announce the appointment of Dr. Morwan Choli as … Read more
Bronwyn Brophy, an Irish national, possesses an impressive resume of leadership positions in some of the world’s most prominent Life Science and Medtech organizations, such … Read more
Ellipses Pharma, a pioneering drug development company committed to transforming cancer treatment, is delighted to announce that the U.S. Food and Drug Administration (FDA) has … Read more
AviadoBio, a groundbreaking gene therapy company at the forefront of developing and delivering life-changing treatments for those suffering from neurodegenerative disorders, is proud to announce … Read more
Adicet Bio, Inc. (Nasdaq: ACET) made a major move on January 31, 2023, granting inducement awards to further its mission of discovering and developing allogeneic … Read more
Sequana Medical NV (Euronext Brussels: SEQUA) proudly announces the granting of a new US patent for its revolutionary DSR (Direct Sodium Removal) program. This groundbreaking … Read more
Amgen (NASDAQ:AMGN) recently held its 2022 fourth quarter and full year financial results webcast, and the full transcript and audio replay are now available for … Read more
Biopharmaceutical innovator Alpha Biopharma proudly announces that the National Medical Products Administration’s Center for Drug Evaluation (CDE) has accepted its New Drug Application (NDA) for … Read more
Aprecia Pharmaceuticals is proud to announce Owen Murray as its new Chief Executive Officer. With Murray at the helm, Aprecia is set to revolutionize the … Read more
Dr. Pavankumar Tandra, a board-certified hematologist and medical oncologist, has joined Florida Cancer Specialists & Research Institute, LLC (FCS)! He is now providing exceptional care … Read more
Moderna’s RSV vaccine candidate has been granted a Breakthrough Therapy Designation by the FDA, a major step forward in the fight against the debilitating respiratory … Read more
Novartis’ hope for a therapeutic breakthrough in the treatment of sickle cell disease, Adakveo (crizanlizumab), is currently under review by the European Medicines Agency’s Committee … Read more
Eli Lilly’s revolutionary new drug, Jaypirca (pirtobrutinib), has just been granted accelerated approval by the FDA for treating adults with relapsed or refractory mantle cell … Read more
Boston is a haven for biotech, boasting an impressive concentration of life sciences companies and the financial resources to back them up. It’s clear that … Read more
Sensorion and EVEON have joined forces to design and develop a revolutionary injection system for the delivery of Sensorion’s gene therapy products to the inner … Read more
On Monday, Amgen confirmed to BioSpace that it is making significant organizational changes, including the layoff of around 300 team members, in order to better … Read more
C-mo Medical Solutions is revolutionizing cough assessment and disease management with the power of digital health! With the recent funding from Novalis Biotech, this pioneering … Read more
MaaT Pharma (EURONEXT: MAAT), a French clinical-stage biotech, is revolutionizing the field of cancer treatment with its pioneering Microbiome Ecosystem TherapiesTM (MET). The Company has … Read more
Sensient Technologies Corporation (NYSE: SXT) is ready to share its fourth quarter and year-end results for 2022 on Friday, February 10, 2023. Join us as … Read more
Kaiser Permanente is proud to announce the appointment of Angela Dowling as their new regional president in Washington. Starting February 13, 2023, she will be … Read more
More than 40 of the world’s most esteemed ophthalmologists, vision researchers, and public health/policy experts are gathering in Mexico for the 2nd Mexico-U.S. Symposium on … Read more
Community Financial Institutions (CFIs) play a vital role in promoting economic and social justice in underserved communities. By providing products and services tailored to the … Read more
Hospital for Special Surgery (HSS) today announced a historic transition for 2023, as Bryan T. Kelly, MD, MBA will become the first surgeon to assume … Read more
Just in time for American Heart Month, XyloCor Therapeutics has released positive topline results from their Phase I/II trial of their groundbreaking gene therapy for … Read more
Merck’s revolutionary cancer treatment, Keytruda (pembrolizumab), has been officially approved by the FDA for the treatment of stage IB, II or IIIA non-small cell lung … Read more
Celularity made a startling announcement on Thursday, revealing that it was undertaking a strategic review and warning its employees to brace for possible job losses. … Read more
Sen. Elizabeth Warren (D-MA) is expressing her concerns about the high-priced acquisitions of Horizon Pharmaceuticals and Opiant Pharmaceuticals by Amgen and Indivior, respectively, in a … Read more
Jaguar Health, Inc. is taking a bold step forward in its mission to make a difference in the rare and orphan disease space. Through its … Read more
Bone Biologics Corporation, a leader in developing orthobiologic products for spine fusion markets, is thrilled to announce their collaboration with Avania, a renowned global, full-service … Read more
BioCentriq, Inc., a New Jersey-based CDMO for cell and gene therapies, has just concluded a study to evaluate the viability, transfection efficiency, and post-transfection growth … Read more
Nogra Pharma, a biotechnology company dedicated to creating groundbreaking therapies for immune-inflammatory-mediated diseases, has just announced a major licensing agreement with Torii Pharmaceutical Co., Ltd. … Read more
Panbela Therapeutics Inc., a clinical stage company developing groundbreaking therapeutics for the treatment of patients with urgent unmet medical needs, has announced the pricing of … Read more
The COVID-19 pandemic has sparked an increased demand for biopharma candidates, with the neuroscience field experiencing a particularly noticeable surge. As this sector continues to … Read more
A startling revelation was made on Tuesday – a previously unknown syndrome with a high mortality rate is far more common than previously thought. The … Read more
Ocuphire Pharma is forging ahead with an FDA end-of-Phase II meeting, despite not achieving the primary endpoint with its oral diabetic retinopathy (DR) drug, APX3330. … Read more
Magenta Therapeutics has placed an immediate pause on the Phase I/II dose-escalation trial of its AML therapy following the unfortunate death of a patient. The … Read more
AC Immune’s anti-amyloid-beta vaccine candidate ACI-24.060 has, according to interim data from the Phase Ib/II ABATE trial, been found to be safe and effective in … Read more
Enlivex Therapeutics Ltd. has made a significant breakthrough in their pioneering macrophage reprogramming immunotherapy clinical trial, as an independent Data and Safety Monitoring Board has … Read more
Today, a review providing evidence-based treatments for early stage Dupuytren’s disease has been published in The Journal of Hand Surgery (European Volume) by 180 Life … Read more
Inhibikase Therapeutics, Inc. has made a breakthrough in the battle against Parkinson’s and related disorders. The company recently published a study in Science Translational Medicine … Read more
Phio Pharmaceuticals Corp., a clinical stage biotechnology company, is taking a bold step forward with its INTASYL™ RNAi platform technology. On January 26, 2023, the … Read more
Jasper Therapeutics, Inc., a biotechnology company that is revolutionizing the field of medicine with its novel antibody therapies, has announced the pricing of an underwritten … Read more
Acasti Pharma Inc., a late-stage specialty pharma company developing treatments for rare and orphan diseases, has been granted a 180-day extension by the NASDAQ Listing … Read more
Clearmind Medicine Inc., a pioneering biotech company devoted to uncovering and developing novel psychedelic-derived therapeutics, proudly announced today that Professor Joseph Tam, D.M.D., Ph.D., presented … Read more
On Wednesday, Small Pharma made a major breakthrough in the development of treatment for major depressive disorder (MDD) when they reported positive results from their … Read more
On Wednesday, three venture capitalists unveiled an exciting new endeavor: Dimension I, a $350 million fund to revolutionize the biotech industry. With this bold move, … Read more
Wednesday was an eventful day for Merck’s blockbuster drug Keytruda (pembrolizumab), as it suffered a rare setback in prostate cancer while simultaneously celebrating a major … Read more
Sanford Burnham Prebys is proud to announce a major recruitment drive, with up to 20 new faculty positions set to be filled in the fields … Read more
Cerevance, a groundbreaking clinical-stage drug discovery and development company focused on central nervous system (CNS) diseases, is proud to announce that Craig Thompson, the company’s … Read more
Dyadic International, Inc., a pioneering biotechnology company, has made a major breakthrough in the fight against COVID-19. The company has initiated dosing in its Phase … Read more
HeartBeam Inc. (NASDAQ: BEAT), a groundbreaking cardiac technology company, is delighted to welcome Robert Eno to their executive team in the newly created position of … Read more
Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) is thrilled to welcome Michael Nketiah to its leadership team as Senior Vice President of Quality, Clinical and Regulatory. … Read more
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on improving treatments to improve lives, recently unveiled real-world data showing the risk of accidental dosing errors with … Read more
The discovery of the genetic basis of VEXAS syndrome in 2020 was a major breakthrough in medical research. But how many people in the United … Read more
Axcella Therapeutics is making strides in the fight against Long COVID fatigue with its AXA1125 therapeutic. On Monday, the U.K.’s Medicines and Healthcare products Regulatory … Read more
On March 22nd, Biogen and Ionis’ experimental therapy for superoxide dismutase 1 (SOD1) ALS, Tofersen, will have its fate in the hands of the FDA’s … Read more
Monday marked a major milestone for Pliant Therapeutics, as the company launched its public offering of $175 million worth of common stock. These funds will … Read more
Tracy Curley, CEO of iSpecimen Inc. (Nasdaq: ISPC), is excited to be part of the Sequire Biotechnology Conference on Thursday, February 2, 2023. As an … Read more
Hemogenyx Pharmaceuticals plc is delighted to announce the successful completion of its third Process Qualification run of the end-to-end manufacturing process for its HEMO-CAR-T cells. … Read more
Today, IntelGenx Corp, a leader in pharmaceutical films, has entered into an exclusive supply agreement with ARWAN Pharmaceuticals Industries Lebanon s.a.l. for their revolutionary product, … Read more
Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, is pleased to announce the completion of a … Read more
MannKind Corporation, a leader in the development and commercialization of inhaled therapeutic products to treat endocrine and orphan lung diseases, today announced the launch of … Read more
Asensus Surgical Inc. has made a thrilling leap forward in medical technology with the CE Mark approval of expanded machine vision capabilities on the previously-cleared … Read more
Today, AstraZeneca, through a subsidiary, begins a tender offer to purchase all outstanding shares of CinCor Pharma, Inc. (CinCor) for a combined $36 per share … Read more
Estar Medical® has had a string of successes this month in its efforts to invalidate Regenlab’s original patent for platelet rich plasma (PRP) at the … Read more
Today, Smart Immune SAS, a clinical-stage biotechnology company, made an exciting announcement: the first adult leukemia patient has been successfully dosed with SMART101, a revolutionary … Read more
Helius Medical Technologies, Inc., a neurotech company with a mission to promote neurological wellness, is pleased to announce preliminary, unaudited results for the quarter and … Read more
On Monday, February 20th, 2023, TC BioPharm (Holdings) PLC, a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, will be … Read more
Catalent, Inc. (NYSE: CTLT) – the global leader in developing, launching and supplying better treatments for patients – will be releasing its financial results for … Read more
Join VolitionRX Limited (NYSE AMERICAN: VNRX) for an exciting webinar hosted by Edison Group! During the event, Volition’s multi-national epigenetics company will be discussing their … Read more
Jazz Pharmaceuticals’ $375 million investment into Zymeworks appears to be a smart move, as the two companies announced “impressive” results on Thursday from a Phase … Read more
CancerVAX, Inc., a pre-clinical biotechnology company on a mission to develop powerful immunotherapy cancer treatments, is proud to announce that CEO Ryan Davies recently shared … Read more
Dr. Reddy’s Laboratories Ltd., a world-leading pharmaceutical company, has achieved a major milestone with the successful completion of all clinical trials for its proposed rituximab … Read more
At SK bioscience, we are dedicated to promoting global health and wellbeing from prevention to cure. Through our cutting-edge vaccine development technologies, we are standing … Read more
SK bioscience, a global leader in innovative vaccine and biotech solutions that prioritize human health, has welcomed Richard Kensinger, PhD, to the team as Vice … Read more
Deciphera Pharmaceuticals, a biopharmaceutical company dedicated to discovering and developing innovative medicines to improve the lives of cancer patients, has announced the pricing of a … Read more
At the American Association for Cancer Research (AACR) special conference on acute myeloid leukemia and myelodysplastic syndrome, taking place January 23-25, 2023 in Austin, TX, … Read more
ANGLE plc, a revolutionary liquid biopsy company, is pleased to welcome Dr. Joseph (Joe) Eid to its board of Non-Executive Directors. Dr. Eid’s appointment will … Read more
Annogen is working to create multiple CNS-cell specific promoters that can be used in VectorY programs. This innovative approach will help to further advance the … Read more
Prenetics Global Limited, a leader in the fields of genomic and diagnostic testing, is proud to announce the appointment of Dr. Bayju Thakar as CEO … Read more
Scenic Biotech, a leader in the groundbreaking world of genetic modifier drugs, has announced the appointment of Kristof Van Emelen, PhD, as Vice President of … Read more
XNK Therapeutics AB has appointed Dr. Peter Hovstadius as its new Chief Medical Officer, effective immediately. He will join the company’s management team, while Dr. … Read more
Last week, NRx Pharmaceuticals, Inc., a clinical-stage central nervous system (CNS) biopharmaceutical company, had a productive meeting with the Food and Drug Administration (FDA), who … Read more
AVAIL SCIENTIFIC is thrilled to announce that it is taking an exciting step forward by entering into a letter of intent (LOI) to acquire Relai … Read more
Teva Pharmaceuticals Industries Ltd is proud to have its targets to reduce greenhouse gas (GHG) emissions approved by the Science Based Targets initiative (SBTi), demonstrating … Read more
Repare Therapeutics Inc., a cutting-edge clinical-stage precision oncology company, announced that it has received a research service payment of approximately $1.5 million (¥200 million) from … Read more
Normunity, Inc., a biotechnology company creating innovative precision anti-cancer immunotherapies, is thrilled to announce the appointment of Olga Granaturova, MBA, as Chief Operating Officer and … Read more
SurModics, Inc. announced that they have received a letter from the U.S. Food and Drug Administration (FDA) regarding their premarket approval (PMA) application for the … Read more
bluebird bio, Inc. announced the pricing of its public offering of 20,000,000 shares of common stock at a public offering price of $6.00 per share, … Read more
Kaneka Corporation is taking the initiative to expand its GMP manufacturing capacity for mRNA with a capital investment of 2 billion JPY. By the end … Read more
Addex Therapeutics Ltd, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today provided a comprehensive corporate update from its headquarters in Geneva, … Read more
KDDI Corporation, based in Tokyo, is proud to announce that its ambitious greenhouse gas (GHG) emissions reduction targets have been validated and approved by the … Read more
Junshi Biosciences announced Wednesday that their Phase III Neotorch trial of the anti-PD-1 monoclonal antibody, toripalimab, had achieved its primary endpoint in non-small cell lung … Read more
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, is proud to announce that its partner SK bioscience has received … Read more
BeiGene is making history by expanding access to life-changing drugs in China! For the first time ever, drugs are being added to the nation’s Reimbursement … Read more
BriaCell Therapeutics Corporation is delighted to announce that its lead clinical candidate, Bria-IMT™, in combination with a checkpoint inhibitor, has been met with agreement and … Read more
The Lupus Research Alliance (LRA) is delighted to announce the appointment of Stacie J. Bell, PhD as Executive Vice President to head up Lupus Therapeutics, … Read more
Cryoablation technology is at the forefront of innovation, and we are proud to be a global leader in this field. Our success is evidenced by … Read more
SOFIE Biosciences, a renowned US-based manufacturer of radiopharmaceuticals, is proud to announce its support of Yantai LNC Biotechnology’s recently FDA-approved clinical study – with the … Read more
Ceruvia Lifesciences made history today, dosing the first participant in their Phase 1 clinical trial of NYPRG-101 (2-bromo-d-lysergic acid diethylamide). The pioneering trial marks an … Read more
Researchers have been able to pinpoint the lowest effective dose of a medication or therapy, thanks to a successful study. This breakthrough provides an invaluable … Read more
Perimeter Medical Imaging AI, Inc. (TSX-V: PINK, OTC: PYNKF, FSE: 4PC) – a commercial-stage medical technology company – is proud to announce its new Board … Read more
Exploring the role of gamma-delta T cells in oncological settings is an exciting area of research with potentially groundbreaking implications. By devoting our attention to … Read more
Aclarion, Inc., a healthcare technology company utilizing biomarkers and proprietary augmented intelligence algorithms to help physicians determine the source of chronic low back pain, is … Read more
A recent study published in the Journal of Clinical Medicine has validated the efficacy of Biobeat’s wrist monitor for advanced noninvasive hemodynamic monitoring in heart … Read more
Agilis RoboticsTM (Agilis) is revolutionizing endoscopic surgery with its groundbreaking robotic instruments. Co-founder Dr. Jason Y.K. Chan recently completed a successful live animal test on … Read more
OncoK9’s potential for detecting cancer recurrence and residual disease after surgery or treatment is impressive, as evidenced by the results of PetDx’s analysis. With its … Read more
Ascletis Pharma Inc. (HKEX: 1672), a China-based biopharmaceutical company, announced today that its wholly owned subsidiary Ascletis Pharmaceuticals Co., Ltd. has entered into a supply … Read more
Scientists from the University of Texas Southwestern Medical Center have made a remarkable breakthrough: using base editing technology, they have managed to repair damaged heart … Read more
We are delighted to report that our clinical trial has produced positive results on both primary and secondary endpoints, allowing us to identify a dose … Read more
World’s First Approved Biosimilar to Actemra® Bio-Thera Solutions, Ltd., a commercial-stage biopharmaceutical company based in Guangzhou, China, has just made a major breakthrough in medical … Read more
CARsgen Therapeutics Holdings Limited (2171.HK) and Huadong Medicine (Hangzhou) Co., Ltd., a subsidiary of Huadong Medicine Co., Ltd. (SZ: 000963), have joined forces in an … Read more
Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA) is delighted to announce a placement of KZA shares to institutional and sophisticated investors in Australia, at a … Read more
Predictive Oncology Inc. (NASDAQ: POAI) is thrilled to announce the appointment of Robert F. Murphy, Ph.D. to its Scientific Advisory Board. With his expertise and … Read more
Cytovance Biologics, a premier biopharmaceutical CDMO of mammalian and microbial biologics, is proud to announce the appointment of Ping Zhang as its new Chief Executive … Read more
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a pioneering biotechnology company dedicated to improving lives by developing precision-engineered medicines to silence diseases, provided … Read more
Introducing CliniPrime Fresh Leukopak, the revolutionary technology that will revolutionize clinical trials and advance the commercialization of advanced therapies. With this launch, we are revolutionizing … Read more
BIOLASE, Inc., the leading global provider of dental lasers, was recently honored with the prestigious Top Workplaces 2022 award from the Orange County Register. The … Read more
Extendicare Inc. (TSX: EXE) declared a cash dividend of C$0.04 per Common Share for the month of January 2023, to be paid out on February … Read more
BioArctic AB’s partner, Eisai, has recently submitted a marketing authorization application for lecanemab, an investigational anti-amyloid beta (Aβ) protofibril[1] antibody for the treatment of mild … Read more
EDP Biotech Corporation is thrilled to welcome Sam Libby as their new Head of Mergers & Acquisitions and Corporate Development. With Libby’s expertise on board, … Read more
VolitionRx Limited (NYSE AMERICAN: VNRX) is proud to announce the launch of its revolutionary Nu.Q® Vet Cancer Test, now available in the United States through … Read more
ALiA BioTech’s rapid diagnostic platform is capable of providing up to 30 accurate results from a single drop of body fluid – whether it be … Read more
Eisai Co., Ltd. and Biogen Inc. have made a groundbreaking announcement today: they have jointly submitted a marketing authorization application for lecanemab, a revolutionary anti-amyloid … Read more
Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197) has made a commitment to use innovative vaccines to save lives and improve public health across the world. Today, … Read more
Enrolling 72 healthy volunteers, we are excited to launch a multiple-dose escalation Phase I clinical trial in the first quarter of 2023. Be a part … Read more
Eli Lilly had an incredible year with the launch of their diabetes drug Mounjaro (tirzepatide). Now, the company is gearing up for an even bigger … Read more
As JP Morgan week kicked off in 2023, Alto Neuroscience was named number seven on BioSpace’s NextGen Bio 2023 list and brought with it positive … Read more
At the 41st J.P. Morgan Healthcare Conference in San Francisco, AbbVie’s CEO Rick Gonzalez talked about the company’s plans to adjust to the impending loss … Read more
Midatech Pharma PLC is delighted to announce that their Phase I study of MTX-110 in recurrent glioblastoma (NCT 05324501) will continue with a planned dose … Read more
IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a Gothenburg-based company developing pioneering treatments for Parkinson’s disease, has nominated a drug candidate from its P003 research … Read more
Pixium Vision has achieved a major milestone — the publication of two peer-reviewed studies showcasing the potential of the Next Generation PRIMA implant to restore … Read more
Biophytis SA (NasdaqCM: BPTS)(Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics to slow the degenerative processes of aging and … Read more
Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company dedicated to the development of oral drug delivery systems, has released the top-line results of its … Read more
iNtRON Biotechnology is delighted to announce that their Tech Transfer process for SAL200, a revolutionary endolysin-based biologic, is entering its final stage! This out-licensing and … Read more
Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP), a biotech business focused on the licensing and reselling of … Read more
MTD Group – a global leader in medical devices – is proud to announce that its affiliate Pikdare S.p.A. has just obtained FDA clearance for … Read more
S2 Genomics, Inc., a leader in single-cell genomics and cell biology applications, is thrilled to announce its new distribution agreement with Bonsailab. This agreement enables … Read more
Our total company net revenue is expected to skyrocket over the next two years! For Q4 of 2021, we forecast an impressive 61% y/y increase, … Read more
Zomedica Corp. (NYSE American:ZOM), a veterinary health company that provides point-of-care diagnostics and therapeutic products for companion animals, announced that CEO Larry Heaton will be … Read more
Apple has been found to be in violation of the Tariff Act of 1930, after a United States Administrative Law Judge in Washington, D.C. determined … Read more
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) granted inducement awards to four new employees under its 2020 Inducement Plan on January 10, 2023. Each employee was offered … Read more
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), has … Read more
BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has made a major move in the fight against Alzheimer’s disease today, submitting a marketing authorization … Read more
Sequana Medical NV (Euronext Brussels: SEQUA), a leader in the treatment of fluid overload in liver disease, heart failure, and cancer, is cordially inviting all … Read more
Fiscal year 2022 was a banner year for Basilea Pharmaceutica Ltd, with significant revenue contributions from the commercial success of Cresemba and Zevtera and proceeds … Read more
Santhera Pharmaceuticals (SIX: SANN) is pleased to announce that, through a share exchange, it will receive the equivalent of CHF 5 million Idorsia shares. This … Read more
Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced a major milestone in its development as the first patient … Read more
IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company dedicated to the development of IgM antibodies, today shared an update on its clinical development program … Read more
NovoCure Ltd. (NASDAQ: NVCR), a global oncology company dedicated to extending survival for those suffering from some of the most aggressive forms of cancer, announced … Read more
PacBio is thrilled to announce the launch of their PacBio Compatible Program, accompanied by positive Onso Beta feedback and preliminary fourth quarter 2022 revenue figures. … Read more
PerkinElmer Inc., a leading innovator driving a healthier world, will announce its fourth quarter and full year 2022 financial results on Tuesday, February 14th, 2023 … Read more
Rani Therapeutics Holdings, Inc. (Nasdaq: RANI) – a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs – today announced an exciting … Read more
SK Inc. is set to spark innovative ideas and identify new business opportunities with its global strategy and growth roadmap at an event attended by … Read more
Introducing a revolutionary new optofluidic system – a two-chip, single-cell device perfect for small to mid-sized biopharma and CDMOs/CROs. Now, you can have access to … Read more
TRex Bio, Inc., a biotechnology company decoding human tissue immune biology to create revolutionary therapeutics, has announced a multi-year research collaboration and exclusive worldwide license … Read more
CONMED Corporation (NYSE: CNMD) today announced that it will report its financial results for the fourth quarter of 2022 after market close on Thursday, February … Read more
Arrowhead Pharmaceuticals announced positive results from the Phase 3 clinical trial of fazirsiran for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). Patients receiving fazirsiran experienced … Read more
Quanterix Corporation (NASDAQ: QTRX) is revolutionizing scientific discovery and breakthrough diagnostics through their ultrasensitive biomarker detection. Today, the company has announced the validation of a … Read more
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, recently granted inducement awards to two … Read more
Precision BioSciences, Inc. (Nasdaq: DTIL) is proud to announce its impressive accomplishments in 2022 and outline its plans for 2023. The clinical-stage gene editing company … Read more
We are proud to report that our total revenue for 2022 is expected to exceed the top end of the guided range of $132–137 million. … Read more
We are excited to announce five pivotal trials in the field of rare hematological diseases, with strong clinical data to support them. Our goal is … Read more
Genexine, a Korean biopharmaceutical company dedicated to discovering and developing treatments for unmet medical needs, has released new results from their Phase 2 clinical study … Read more
PBS Biotech, a leader in single-use bioreactors and process development services, recently announced the completion of a $22 million financing round led by Avego Management, … Read more
BioArctic AB’s partner Eisai announced today that they have submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) in … Read more
ChromaDex Inc. (NASDAQ: CDXC), a leading bioscience company devoted to healthy aging, is delighted to announce the appointment of Brianna Gerber as its new Chief … Read more
IONIQ Sciences, Inc., formerly known as ProLung, Inc., is excited to announce its attendance at Biotech Showcase™, the globally renowned investor conference for innovators. CEO … Read more
We are thrilled to be advancing our small molecule therapeutic candidates, which have promising clinical and preclinical data suggesting neuroprotective, neurotrophic, procognitive, and disease-modifying effects. … Read more
HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, is … Read more
Kira Pharmaceuticals, a biotechnology leader in cutting-edge complement therapies to treat immune-mediated diseases, is proud to announce that Frederick Beddingfield M.D., Ph.D., Chief Executive Officer, … Read more
Triumvira Immunologics, a clinical-stage company developing groundbreaking T cell therapies to fight solid tumors, today announced a clinical trial collaboration and supply agreement with Merck. … Read more
Looking for the biotech industry’s hottest spots? Look no further than BioSpace’s exclusive Hotbed Maps! Our vibrant, one-of-a-kind map highlights the nine regions to watch … Read more
Metagenomi is starting the new year off with a bang, having just secured an additional $100 million in a Series B extension financing round announced … Read more
NovoCure Ltd., based in Switzerland, has just announced that its Phase III LUNAR trial has successfully met its primary endpoint in patients with non-small cell … Read more
As the FDA nears its decision on Biogen and Eisai’s lecanemab, a new potential death linked to the Alzheimer’s drug has been revealed in a … Read more
Galmed Pharmaceuticals’ synthetic small molecule candidate, aramchol, has proven to be a powerful tool in the fight against non-alcoholic steatohepatitis (NASH), following Phase III ARMOR … Read more
Emergent Health Corp. (OTC PINK:EMGE), a leading provider of innovative products in the Regenerative Health Space, has reported an impressive 100% quarter-over-quarter revenue increase for … Read more
Psilocybin-assisted psychotherapy appears to be a promising treatment approach for Binge Eating Disorder, with preliminary research showing encouraging results. By combining the power of psychedelic-assisted … Read more
Duality is thrilled to announce the granting of a license for its DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP … Read more
Ascentage Pharma (6855.HK), a pioneering biopharmaceutical company revolutionizing the way cancer, chronic hepatitis B (CHB), and age-related diseases are treated, is thrilled to announce that … Read more
YDS Pharmatech, Inc., a techbio startup revolutionizing drug design with its low-data-dependent AI solutions, is proud to present its latest innovations at Biotech Showcase™ 2023. … Read more
InnoCare Pharma (HKEX: 09969; SSE: 688428), a pioneering biopharmaceutical company dedicated to the treatment of cancer and autoimmune diseases, is pleased to announce that it … Read more
WuXi Biologics has just signed an exclusive license agreement with GSK that grants them access to preclinical bi-specific T cell engaging (TCE) antibodies, with the … Read more
JPMorgan week is proving to be a successful return to the pre-pandemic days, with executives flocking to San Francisco after two years of COVID-19-enforced absence. … Read more
Innovent Biologics, Inc. – a leading global biopharmaceutical company – has been granted Breakthrough Therapy Designation (BTD) by China’s National Medical Products Administration (NMPA) for … Read more
Virax Biolabs, a cutting-edge biotechnology firm dedicated to the prevention, detection, and diagnosis of viral diseases, has just announced the launch of its HPV test … Read more
The FOURIER trial recently revealed that Amgen’s injectable cholesterol therapeutic, Repatha (evolocumab), may lead to an increased risk of cardiovascular death. This finding was revealed … Read more
Pharnext SA (FR001400BV89:ALPHA), an innovative biopharmaceutical company that is developing groundbreaking treatments for neurodegenerative disorders with an urgent need for solutions, is delighted to welcome … Read more
Oncopeptides AB (publ.) (Nasdaq Stockholm: ONCO), a biotech company dedicated to advancing treatments for hard-to-treat hematologic diseases, has appointed Dr Monica Shaw as its new … Read more
We are thrilled to announce that we have secured exclusive global rights to a potentially best-in-class gene therapy for Spinal Muscular Atrophy from UMass Chan … Read more
Bioretec Ltd, a leader in bioresorbable orthopedic implants, have received confirmation from the FDA that their supplement for the market authorization request for the RemeOs™ … Read more
Sanofi proudly announced today that the Memorandum for Q4 2022, for modelling purposes, is now available for investors to access on the company’s website. This … Read more
Orano Med, a pioneering clinical stage radiopharmaceutical company, today announced a major breakthrough with the first patient being dosed in their Phase 1 trial of … Read more
Hemogenyx Pharmaceuticals plc (LSE:HEMO) is thrilled to report the successful accomplishment of its second Process Qualification (“PQ”) run of the end-to-end manufacturing process for its … Read more
Sedana Medical AB (publ) (SEDANA: FN Stockholm) is thrilled to announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) … Read more
TherapeuticsMD, Inc. (NASDAQ: TXMD) has successfully completed the previously announced transaction with Mayne Pharma Group Limited, an ASX-listed specialty pharmaceutical company. Through this agreement, TherapeuticsMD … Read more
Phase 3 Trials for a potential new treatment are set to begin enrollment in the second quarter of 2023, pending discussions with the FDA. Exciting … Read more
ResMed (NYSE: RMD, ASX: RMD) is pleased to announce that Mick Farrell, its chief executive officer, will take the stage at the 41st Annual J.P. … Read more
Blacksmith Medicines and Forge Therapeutics are joining forces to revolutionize the biopharma industry with a groundbreaking merger. Combining their chemistry platforms, the companies are dedicated … Read more
argenx, a global immunology company dedicated to transforming the lives of those living with severe autoimmune diseases, is proud to announce that its Chief Executive … Read more
Antengene Corporation Limited (SEHK: 6996.HK) is thrilled to announce that it will be presenting at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January … Read more
Photocure ASA, The Bladder Cancer Company, is pleased to announce the publication of a groundbreaking study in Urologic Oncology this week. Entitled ‘Clinical and Economic … Read more
Masimo SpHb has been shown to measure hemoglobin levels with “clinically acceptable accuracy” – even at the lowest levels. This breakthrough technology offers reliable and … Read more
Minovia Therapeutics, a clinical-stage global biotechnology company, is thrilled to announce its attendance at the upcoming Biotech Showcase in San Francisco, CA on Tuesday, January … Read more
Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) held its Annual General Meeting of Shareholders in Vancouver, British Columbia on December 30, 2022, with … Read more
MedMira Inc. (TSXV:MIR) unveiled its financial results for the quarter ending October 31, 2022, revealing a period of strong growth and increased profitability. The Halifax-based … Read more
The submission to regulatory authorities is a crucial step towards obtaining marketing authorization for the use of a new treatment in the fight against unresectable … Read more
Building on the promising results of its monotherapeutic activity in a previous clinical trial, ONC-392 is now entering Phase 2 of a multicenter, open-label combination … Read more
Astex Pharmaceuticals, UK, is proud to congratulate its co-founder, President and CEO, Harren Jhoti, PhD, FRS, FMedSci, on being honoured with an Officer of the … Read more
“Two Years and Older: Negative COVID-19 Test Now Required for Air Travel to Canada!” In response to the surge of COVID-19 cases in the People’s … Read more
Experts have expressed their concerns that the loosening of China’s COVID-19 restrictions could lead to an increased risk of the virus mutating. William Schaffner, professor … Read more
Pfizer Inc. (NYSE: PFE) announced today the positive top-line results from the Phase 3 BENEGENE-2 study (NCT03861273) of its investigational gene therapy, fidanacogene elaparvovec, for … Read more
Evofem Biosciences, Inc. (OTCQB: EVFM) has been granted an extension by the OTC Markets Group to submit its Quarterly Report on Form 10-Q for the … Read more
With extensive experience in the industry, a new director has been appointed to position the company for growth. This individual brings an impressive knowledge base … Read more
Everest Medicines (HKEX: 1952), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative medicines and vaccines, is proud to announce its new corporate strategy. … Read more
ABM Respiratory Care, a leading medical technology company, is excited to announce the U.S. Food and Drug Administration’s 510(k) clearance of its groundbreaking BiWaze® Clear … Read more
Néovacs has made a significant commitment to increase its funding for the upcoming pivotal Phase III clinical trial of PXT3003, a potential treatment for Charcot-Marie-Tooth … Read more
NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) (“NuGen” or the “Company”) has successfully closed the first tranche of its non-brokered private placement, raising a total of $125,000 … Read more
NXC-201, a pioneering CAR-T therapy for multiple myeloma and AL amyloidosis, will have its latest clinical data unveiled at the upcoming Rotterdam event on February … Read more
Come join us in Rotterdam, Netherlands February 9-11, 2023 for the presentation of updated clinical data on NXC-201, a next-generation CAR-T treatment for multiple myeloma … Read more
The National Cancer Institute recently conducted a Phase 2 clinical trial to assess the efficacy of PDS0101 triple combination in treating HPV16-positive cancer patients who … Read more
Varex Imaging Corporation (Nasdaq: VREX) is thrilled to announce its participation in CJS Securities 23rd Annual New Ideas for the New Year virtual investor conferences, … Read more
CEL-SCI Corporation (NYSE American: CVM) recently announced its financial results for the fiscal year ended September 30, 2022, along with several noteworthy clinical and corporate … Read more
XENOVIEW is a groundbreaking hyperpolarized MRI contrast agent that is the first and only of its kind to receive FDA approval for both adolescents and … Read more
Alphatec Holdings, Inc. (Nasdaq: ATEC) is excited to announce its virtual participation in the 25th Annual Needham Growth Conference! Join us on January 12, 2023 … Read more
Stryker (NYSE: SYK) has announced an upcoming conference call to review the company’s performance for the quarter ending December 31, 2022, and provide an operational … Read more
Akoya Biosciences, Inc. (Nasdaq: AKYA) – The Spatial Biology Company® – is thrilled to announce that it will be taking part in the 41st Annual … Read more
Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) is proud to announce that their Phase 3 trial (NCT05341609) comparing the efficacy and … Read more
Qilu Pharmaceutical is making waves in the medical industry with its innovative bifunctional antibody, QL1706, by presenting the latest progress of its clinical studies at … Read more
Skanska and HGR General Contractors have teamed up to construct a state-of-the-art medical education building for The University of Texas at Tyler. The contract, worth … Read more
Skanska has secured a USD 95M (SEK 960M) contract to expand the Christus Santa Rosa Hospital-Westover Hills Hospital in San Antonio, Texas, USA. The project … Read more
Guardant Health, Inc. (Nasdaq: GH), a cutting-edge precision oncology company, is pleased to announce its attendance at the upcoming 41st Annual J.P. Morgan Healthcare Conference. … Read more
RxSight Inc., a leading ophthalmic medical device company committed to restoring the vision of cataract surgery patients, is thrilled to announce its participation in the … Read more
Cardio Diagnostics Holdings Inc (Nasdaq: CDIO) and Houston Concierge Medicine have joined forces to provide a revolutionary new test for coronary heart disease. Cardio Diagnostics’ … Read more
Harm Reduction Therapeutics (HRT), Inc., the 501(c)(3) nonprofit pharmaceutical company working to prevent opioid overdose deaths, has made an exciting breakthrough: the FDA has accepted … Read more